Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer [Phase 1]
A Phase 1 study is evaluating neoadjuvant SGLT2 inhibitors for localized prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients [NA]
A clinical trial update shows a study evaluating the feasibility of stopping prostate cancer treatment early in elderly patients; the trial …
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy [NA]
Ongoing University of Chicago clinical trial evaluating MRI-based risk maps for diagnosing prostate cancer using targeted biopsy. The study …
-
EMA approval · 2025-09-30EMA Authorised: Orgovyx (relugolix) — Accord Healthcare S.L.U.
The European Medicines Agency has authorised Orgovyx (relugolix) for the treatment of prostate cancer (prostatic neoplasms) in the European …
-
EMA approval · 2025-09-30EMA Authorised: Jevtana (cabazitaxel) — Sanofi Winthrop Industrie
The European Medicines Agency authorised Jevtana (cabazitaxel) for prostate cancer, with Sanofi Winthrop Industrie as the marketing authoriz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL) [Phase 1]
This is a Phase 1 clinical trial investigating radiotherapy to the prostate and the dominant intra-prostatic lesion (DIL) for prostate cance…
-
CLINICAL_TRIALS withdrawal · 2025-09-30Clinical Trial Update: Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology [Phase 2]
Phase 2 clinical trial evaluating abbreviated biparametric MRI (RSI + T2WI) for prostate cancer detection has been withdrawn.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer [Phase 1, Phase 2]
This is a clinical trial update describing a Phase 1/Phase 2 study of QLC5508 and QLH12016 in combination with other anti-tumor therapies fo…
-
CLINICAL_TRIALS withdrawal · 2025-09-29Clinical Trial Update: Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer [Phase 2]
Phase 2 trial assessing race-related differences in the efficacy of niraparib plus abiraterone acetate and prednisone in homologous recombin…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors [NA]
A clinical trial evaluating exercise to target metabolic dysregulation in stage I-III breast and prostate cancer survivors has been terminat…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU [NA]
An early-stage clinical trial update comparing prostate cancer–related quality of life after total prostatectomy versus focal high-intensity…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging [NA]
This is a clinical trial registration for a randomized prospective multicenter study aiming to diagnose clinically significant prostate canc…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Evaluating Tolerability of ePUHRT With Brachytherapy Boost [NA]
Clinical trial evaluating tolerability of ePUHRT with a brachytherapy boost for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
This clinical trial update describes a study evaluating outcomes after prostate cancer diagnosis and treatment in carriers of rare germline …
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: The BARCODE 1 Pilot Study
BARCODE 1 is a pilot study sponsored by the Institute of Cancer Research in the United Kingdom that investigates prostate cancer. The trial …
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Clinical trial IMPACT studies genetic predisposition to prostate cancer in men; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: 68Ga-NTA-476 Imaging in Prostate Cancer [EARLY_Phase 1]
An early-phase trial evaluating the 68Ga-NTA-476 imaging agent for detecting prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer [EARLY_Phase 1]
Early Phase 1 dosimetry study of two Lutetium-177 radiopharmaceuticals (rhPSMA-10.1 and lutetium-177 vipivotide tetraxetan) in patients with…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Connect2Care: Prostate Cancer Education and Screenings for African American Men [NA]
This clinical trial update describes the Connect2Care program to educate African American men about prostate cancer and provide screenings; …
-
FDA approval · 2025-09-23FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., authorizing an updated indicati…
-
FDA approval · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for leuprolide acetate (generic) submitted by Eugia US LLC under an ANDA.
-
FDA label_change · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Leuprolide acetate filed by NorthStar RxLLC, indicating an update to the product labeling.
-
FDA label_change · 2025-09-23FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc)
FDA approved a supplemental application for Leuprolide acetate submitted by Meitheal Pharmaceuticals Inc.
-
FDA approval · 2025-09-23FDA Approved: TRIPTODUR — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIPTODUR (triptorelin) from Azurity Pharmaceuticals, Inc.
-
FDA label_change · 2025-09-23FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
FDA approved a supplemental application for ZOLADEX (goserelin) submitted by TerSera Therapeutics LLC. The approval updates the label to ref…